Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG).

Tsironis G, Koutsoukos K, Athanasakis K, Tsiara A, Tzannis K, Gerolympou M, Visvikis A, Oikonomopoulos G, Kollia A, Giannopoulou E, Dimitra M, Kostouros E, Papatsoris A, Dellis A, Stravodimos K, Varkarakis I, Samantas E, Aravantinos G, Kentepozidis N, Christodoulou C, Bozionelou V, Dimopoulos MA, Bamias A.

Expert Rev Pharmacoecon Outcomes Res. 2018 Nov 10:1-11. doi: 10.1080/14737167.2019.1546121. [Epub ahead of print]

PMID:
30417707
2.

Ablation energies for focal treatment of prostate cancer.

Lodeizen O, de Bruin M, Eggener S, Crouzet S, Ghai S, Varkarakis I, Katz A, Dominguez-Escrig JL, Pahernik S, de Reijke T, de la Rosette J.

World J Urol. 2018 Jun 25. doi: 10.1007/s00345-018-2364-x. [Epub ahead of print]

PMID:
29943219
3.

The Impact of Technique Standardization on Total Operating and Fluoroscopy Times in Simple Endourological Procedures: A Prospective Study.

Dellis AE, Skolarikos AA, Nastos K, Deliveliotis C, Varkarakis I, Mitsogiannis I, Chrissofos M, Papatsoris AG.

J Endourol. 2018 Aug;32(8):747-752. doi: 10.1089/end.2018.0265. Epub 2018 Jul 2.

PMID:
29845884
4.

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.

Liontos M, Trigka EA, Korkolopoulou P, Tzannis K, Lainakis G, Koutsoukos K, Kostouros E, Lykka M, Papandreou CN, Karavasilis V, Christodoulou C, Papatsoris A, Skolarikos A, Varkarakis I, Adamakis I, Alamanis C, Stravodimos K, Mitropoulos D, Deliveliotis C, Constantinidis CA, Saetta A, Patsouris E, Dimopoulos MΑ, Bamias A.

World J Urol. 2017 Mar;35(3):411-419. doi: 10.1007/s00345-016-1890-7. Epub 2016 Jul 9.

PMID:
27395374
5.

Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.

van den Bos W, Jurhill RR, de Bruin DM, Savci-Heijink CD, Postema AW, Wagstaff PG, Muller BG, Varkarakis IM, Skolarikos A, Zondervan PJ, Laguna Pes MP, de Reijke TM, de la Rosette JJ.

J Urol. 2016 Aug;196(2):552-9. doi: 10.1016/j.juro.2016.02.2977. Epub 2016 Mar 19.

PMID:
27004693
6.

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.

Postema AW, De Reijke TM, Ukimura O, Van den Bos W, Azzouzi AR, Barret E, Baumunk D, Blana A, Bossi A, Brausi M, Coleman JA, Crouzet S, Dominguez-Escrig J, Eggener S, Ganzer R, Ghai S, Gill IS, Gupta RT, Henkel TO, Hohenfellner M, Jones JS, Kahmann F, Kastner C, Köhrmann KU, Kovacs G, Miano R, van Moorselaar RJ, Mottet N, Osorio L, Pieters BR, Polascik TJ, Rastinehad AR, Salomon G, Sanchez-Salas R, Schostak M, Sentker L, Tay KJ, Varkarakis IM, Villers A, Walz J, De la Rosette JJ.

World J Urol. 2016 Oct;34(10):1373-82. doi: 10.1007/s00345-016-1782-x. Epub 2016 Feb 18. Review.

7.

MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.

van den Bos W, de Bruin DM, van Randen A, Engelbrecht MR, Postema AW, Muller BG, Varkarakis IM, Skolarikos A, Savci-Heijink CD, Jurhill RR, Zondervan PJ, Laguna Pes MP, Wijkstra H, de Reijke TM, de la Rosette JJ.

Eur Radiol. 2016 Jul;26(7):2252-60. doi: 10.1007/s00330-015-4042-3. Epub 2015 Oct 8.

8.

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.

Pistamaltzian N, Tzannis K, Pissanidou V, Peroukidis S, Milaki G, Karavasilis V, Mitsogiannis I, Varkarakis I, Papatsoris A, Dellis A, Adamakis I, Stravodimos K, Molyva D, Athanasiadis I, Androulakis N, Andreadis C, Kalofonos C, Mitropoulos D, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A.

Anticancer Drugs. 2016 Jan;27(1):48-53. doi: 10.1097/CAD.0000000000000297.

9.

VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases.

Kostakopoulos N, Protogerou V, Skolarikos A, Varkarakis I, Papatsoris A, Troupis T, Piagou M, Deliveliotis C.

Ann Ital Chir. 2015 Jul-Aug;86(4):362-7.

PMID:
26344154
10.

The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.

van den Bos W, de Bruin DM, Jurhill RR, Savci-Heijink CD, Muller BG, Varkarakis IM, Skolarikos A, Zondervan PJ, Laguna-Pes MP, Wijkstra H, de Reijke TM, de la Rosette JJ.

World J Urol. 2016 May;34(5):657-64. doi: 10.1007/s00345-015-1661-x. Epub 2015 Aug 22.

11.

Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis.

Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, Castillo O, Matei DV, Celia A, Koc G, Vora A, Aron M, Parsons JK, Pini G, Jensen JC, Sutherland D, Cathelineau X, Nuñez Bragayrac LA, Varkarakis IM, Amparore D, Ferro M, Gallo G, Volpe A, Vuruskan H, Bandi G, Hwang J, Nething J, Muruve N, Chopra S, Patel ND, Derweesh I, Champ Weeks D, Spier R, Kowalczyk K, Lynch J, Harbin A, Verghese M, Samavedi S, Molina WR, Dias E, Ahallal Y, Laydner H, Cherullo E, De Cobelli O, Thiel DD, Lagerkvist M, Haber GP, Kaouk J, Kim FJ, Lima E, Patel V, White W, Mottrie A, Porpiglia F.

Eur Urol. 2015 Jul;68(1):86-94. doi: 10.1016/j.eururo.2014.11.044. Epub 2014 Dec 4.

12.

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.

van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, Laguna Pes MP, Veelo DP, Savci Heijink CD, Engelbrecht MR, Wijkstra H, de Reijke TM, de la Rosette JJ.

BMJ Open. 2014 Oct 29;4(10):e006382. doi: 10.1136/bmjopen-2014-006382.

13.

Modified S-ileal neobladder for continent urinary diversion: functional and urodynamic results after 20 years of follow-up.

Dellis AE, Papatsoris AG, Skolarikos AA, Varkarakis IM, Deliveliotis CN.

Urol Int. 2014;93(1):43-8. doi: 10.1159/000356283. Epub 2014 Apr 9.

PMID:
24731960
14.

Defining prostate cancer risk after radical prostatectomy.

Adamis S, Varkarakis IM.

Eur J Surg Oncol. 2014 May;40(5):496-504. doi: 10.1016/j.ejso.2014.02.221. Epub 2014 Feb 20. Review.

PMID:
24613741
15.

Pathological characteristics, biochemical recurrence and functional outcome in radical prostatectomy patients on statin therapy.

Kontraros M, Varkarakis I, Ntoumas K, Deliveliotis C.

Urol Int. 2013;90(3):263-9. doi: 10.1159/000346751. Epub 2013 Mar 20.

PMID:
23548958
16.

Update on intracorporeal laser lithotripsy.

Papatsoris A, Chrisofos M, Skolarikos A, Varkarakis I, Mitsogiannis I, Mygdalis V, Dellis A, Buchholz N, Masood J.

Minerva Med. 2013 Feb;104(1):55-60. Review.

PMID:
23392538
17.

Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen.

Varkarakis I, Zarkadoulias A, Bourdoumis A, Chatzidarellis E, Antoniou N, Deliveliotis C.

Urol Oncol. 2013 Oct;31(7):1038-42. doi: 10.1016/j.urolonc.2011.11.033. Epub 2011 Dec 22.

PMID:
22196747
18.

Extraperitoneal laparoscopic Millin prostatectomy using finger enucleation.

Chlosta PL, Varkarakis IM, Drewa T, Dobruch J, Jaskulski J, Antoniewicz AA, Borówka A.

J Urol. 2011 Sep;186(3):873-6. doi: 10.1016/j.juro.2011.04.080. Epub 2011 Jul 23.

PMID:
21788034
19.

High-risk laparoscopic urologic surgery.

Varkarakis I, Chatzidarellis EP, Deliveliotis C.

J Endourol. 2010 Aug;24(8):1219-28. doi: 10.1089/end.2009.0484. Review.

PMID:
20109121
20.

Reducing the number of sutures for vesicourethral anastomosis in radical retropubic prostatectomy.

Mazaris EM, Chatzidarellis E, Varkarakis IM, Dellis A, Deliveliotis C.

Int Braz J Urol. 2009 Mar-Apr;35(2):158-63.

Supplemental Content

Loading ...
Support Center